We are grateful to Shaw et al [...].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019583 | PMC |
| http://dx.doi.org/10.3390/nu12010140 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Editorial: Can dietary gluten restriction improve hepatic steatosis? Authors' reply.
Aliment Pharmacol Ther
June 2024
Metabolic Liver Disease Research Program, I. Department of Medicine, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Gluten and non-coeliac gluten sensitivity: the nocebo effect and future avenues - Authors' reply.
Lancet Gastroenterol Hepatol
April 2024
Department of Gastroenterology-Hepatology, Maastricht University Medical Center+, Maastricht, Netherlands; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Netherlands. Electronic address:
Editorial: coeliac disease follow-up guided by gluten immunogenic peptides-are we there yet? Authors' reply.
Aliment Pharmacol Ther
June 2023
Digestive Disease Clinical Unit and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío Hospital/CSIC/US, Seville, Spain.
Editorial: gluten-free but not pain-free in IBS-authors' reply.
Aliment Pharmacol Ther
December 2022
Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Editorial: lack of gastrointestinal symptoms caused by gluten in patients without coeliac disease-time to ditch the 'gluten' from 'non-coeliac gluten sensitivity'. Authors' reply.
Aliment Pharmacol Ther
July 2022
Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!